Controlled-Release Basic Fibroblast Growth Factor for Peripheral Artery Disease: Comparison with Autologous Bone Marrow-Derived Stem Cell Transfer
Authors:
- 1 November 2011
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 17 (21-22) , 2787-2794
Abstract
Objective: We examined the safety and efficacy of controlled-release basic fibroblast growth factor (b-FGF) for peripheral artery disease (PAD), compared with autologous bone marrow mononuclear cell implantation (BMCI). Background: We recently developed a b-FGF-incorporated biodegradable hydrogel that enables slow-releasing drug delivery system. Methods: PAD patients were divided into a b-FGF group (n=10) and BMCI group (n=15). Injection of gelatin hydrogel containing 600 μg b-FGF or BMCI (0.4–5.1×1010 cell) was performed. Visual analog pain scale (VAS), 99mtechnetium-tetrofosmin (Tc-TF) scintigraphy, transcutaneous oxygen tension (TcPO2), and ankle-brachial index (ABI) were evaluated before and 4 weeks after each treatment, and 2-year prognosis was determined. Results: VAS (b-FGF 67±15 to 4±5, pp2 (b-FGF 16±14 to 47±17, ppConclusion: Controlled-release b-FGF is as safe as BMCI, and its efficacy appears to be comparable. Thus, this therapy may be an alternative to BMCI.Keywords
This publication has 30 references indexed in Scilit:
- Therapeutic Angiogenesis by Controlled-Release Fibroblast Growth Factor in a Patient With Churg-Strauss Syndrome Complicated by an Intractable Ischemic Leg UlcerThe American Journal of the Medical Sciences, 2009
- Promoting Mechanisms of Vascular HealthJACC, 2009
- Angiogenesis: an organizing principle for drug discovery?Nature Reviews Drug Discovery, 2007
- Critical Roles of Muscle-Secreted Angiogenic Factors in Therapeutic NeovascularizationCirculation Research, 2006
- Update on therapeutic neovascularizationCardiovascular Research, 2005
- Therapeutic angiogenesis in cardiovascular diseaseNature Reviews Drug Discovery, 2003
- Angiogenesis of the heartMicroscopy Research and Technique, 2003
- Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidneyKidney International, 1999
- Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.Journal of Clinical Investigation, 1995
- Exercise and Intermittent ClaudicationCirculation, 1969